GleamWall
中文EN

DRIO DarioHealth Corp.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1533998 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-13.9%
TTM net income YoY19.5%
TTM EPS YoY-67.7%
Revenue 3-yr CAGR-3.3%
Net income 3-yr CAGR—

Margins

Gross margin57.9%
Operating margin-142.7%
Net margin-159.9%
FCF margin-111.0%
EBITDA margin-141.7%

Returns

ROE-46.6%
ROA-29.6%
ROIC (approx.)-32.4%
Asset turnover0.19x

Leverage & solvency

Liabilities / assets36.6%
Debt / equity0.44x
Current ratio4.20x
Interest coverage-6.81x

Cash quality & payout

Operating cash flow / net income0.69x
Accruals ratio-9.1%
Payout ratio—
Capex / revenue0.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$5.31M$5.18M$5.58M$5.23M$5.01M$5.37M$6.75M$7.60M
Cost of revenue$2.17M$1.99M$2.38M$2.43M$1.99M$2.40M$2.87M$3.40M
Gross profit$3.15M$3.19M$3.20M$2.80M$3.02M$2.96M$3.88M$4.20M
R&D expense$2.29M$2.10M$2.38M$2.63M$3.33M$3.72M$4.11M$5.28M
SG&A expense$4.08M$2.60M$3.23M$4.10M$4.57M$3.21M$3.31M$5.01M
Operating income-$8.04M-$6.48M-$7.31M-$8.56M-$9.48M-$9.20M-$9.41M-$11.67M
Interest expense$1.09M$1.12M$1.15M$1.10M$1.16M———
Pretax income-$8.87M-$7.60M-$8.19M-$8.95M-$10.47M-$12.99M-$9.21M-$9.48M
Income tax-$18,000$328,000$57,000$83,000$0$0$22,000$155,000
Net income-$8.85M-$7.92M-$8.25M-$9.03M-$10.47M-$12.99M-$9.23M-$9.63M
EBITDA-$8.00M-$6.43M-$7.25M-$8.50M-$9.41M-$9.12M-$9.31M-$11.11M
EPS (basic)0.730.851.25—2.963.542.87—
EPS (diluted)0.730.851.25—2.963.542.87—
Weighted avg. shares (diluted)12.06M9.34M6.58M—3.14M2.48M2.37M—
Balance sheet
Cash & equivalents$27.84M$6.63M$14.98M$21.80M$31.91M$21.95M$27.85M$27.76M
Short-term investments$3.31M$7.33M$5.04M$4.21M————
Inventory$3.54M$3.72M$4.17M$4.32M$4.87M$4.61M$4.62M$4.75M
Current assets$38.49M$22.13M$28.73M$35.07M$42.19M$32.17M$38.56M$40.53M
PP&E, net$479,000$503,000$511,000$549,000$578,000$610,000$646,000$709,000
Goodwill$57.43M$57.43M$57.43M$57.43M$57.43M$57.43M$57.43M$57.43M
Intangibles$14.53M$15.00M$15.47M$15.93M$16.41M$16.88M$17.60M$18.76M
Total assets$112.43M$96.59M$103.28M$110.08M$117.73M$108.33M$115.60M$118.88M
Current liabilities$9.17M$9.58M$9.36M$9.32M$9.28M$9.75M$19.16M$16.64M
Short-term debt——————$10.29M$5.45M
Long-term debt$31.25M$31.06M$30.93M$30.75M$30.62M$30.50M$18.90M$23.47M
Total debt$31.25M$31.06M$30.93M$30.75M$30.62M$30.50M$29.19M$28.92M
Total liabilities$41.16M$41.50M$40.90M$42.15M$42.79M$44.34M$41.90M$46.87M
Shareholders' equity$71.27M$55.09M$62.38M$67.92M$74.93M$63.99M$73.70M$72.02M
Net debt$3.40M$24.43M$15.95M$8.94M-$1.29M$8.54M$1.34M$1.16M
Shares outstanding11.20M7.34M7.30M6.91M6.77M45.47M42.71M1.92M
Cash flow statement
Operating cash flow-$5.54M-$6.08M-$6.03M-$5.89M-$7.35M-$6.03M-$6.67M-$6.73M
Capital expenditure$27,000$38,000$31,000$26,000$41,000$44,000$31,000$21,000
Free cash flow-$5.57M-$6.12M-$6.06M-$5.91M-$7.39M-$6.08M-$6.70M-$6.75M
Investing cash flow$3.97M-$2.29M-$826,000-$4.23M-$41,000-$44,000-$31,000-$21,000
Financing cash flow———-$19,000$17.39M$124,000$6.82M$18.32M
Depreciation & amortization$50,000$47,000$61,000$60,000$73,000$80,000$94,000$554,000
Stock-based compensation$2.21M$632,000$1.44M$2.04M$2.95M$2.04M$2.34M-$13.16M

Free plan shows the latest 8 periods; Pro shows all 59 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.